Aminologics아미노로직스
074430 · KOSDAQ · ₩074430 · 아미노로직스
₩1,009▲ ₩9 (0.90%)End-of-day · Oct 30, 2026 · End-of-day prices.
Margins
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Gross margin | 47.4% | 44.8% | 20.4% | 37.2% | 46.9% | 40.0% |
| Operating margin | 20.9% | 16.3% | −12.8% | 7.0% | 25.7% | 18.0% |
| Net margin | 12.1% | 16.0% | −9.6% | 11.7% | −26.6% | 23.5% |
Growth (year on year)
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue growth | +18.8% | +31.1% | −19.6% | −23.6% | +19.6% | — |
| Operating income growth | +52.5% | +266.9% | −247.3% | −79.2% | +71.4% | — |
| Net income growth | −10.3% | +317.4% | −166.5% | +133.5% | −235.9% | — |
Returns
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Return on equity | 5.5% | 6.5% | −3.1% | 4.6% | −13.1% | 9.0% |
| Return on assets | 5.1% | 5.0% | −2.8% | 4.3% | −12.1% | 8.2% |
Leverage and liquidity
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Liabilities to equity | 53.5% | 50.3% | 9.9% | 6.0% | 8.1% | 9.8% |
| Net debt to equity | −11.8% | −19.7% | −34.6% | −20.2% | −22.8% | −13.2% |
| Current ratio | 228.1% | 285.1% | 1,071.3% | 1,696.3% | 1,270.8% | 718.8% |
Calculated from filed financial statements. TTM = trailing 12 months.
Also known as: Aminologics / 아미노로직스 / 074430 / KRX:074430
Source: KRX statistical information